Introduction
It is now well established that many antitumor agents, which interact with dierent targets, can kill chemosensitive leukemic cells via an apoptotic process (Fisher, 1994; Hickman, 1992) . Without oblating the classical mechanisms of resistance, for instance the modulation of intracellular drug concentration, enhanced drug metabolism, drug-target ampli®cation or repair of damaged targets, the regulation of apoptosis appears, downstream of the drug-target interactions, as a new concept of drug resistance (Hickman, 1992; Reed, 1995) . Apoptosis is a genetically encoded cell death program de®ned by morphological and biochemical events (Cohen, 1993; White, 1996; Williams and Smith, 1993; Wyllie, 1980) . This cell death pathway may be in¯uenced by dierent factors such as the tumor cell type, the dierentiation status, growth factors, or oncogenes (reviewed by White, 1996) .
Among the regulators of apoptosis, the oncogene Bcl-2, initially identi®ed at the breakpoint of the t(14;18) chromosomal translocation that occurs in follicular lymphomas, appears as a potent antiapoptotic gene (reviewed by Reed, 1995) . Bcl-2 belongs to a growing gene family with structural and functional homologies (Reed, 1995; White, 1996) . Some of these gene products, such as Bcl-2, Bcl-x L , Mcl-1, A1, have anti-apoptotic properties; other gene products such as Bax, Bcl-x S , Bad, or Bak behave as proapoptotic genes (for a review see White, 1996) . It has been shown that several of these proteins have the capacity to form homodimers or heterodimers with some of their homologues ; reviewed by White, 1996) . Thus it is probably a balance between the various associations of pro-and anti-apoptotic genes that determines the ultimate fate of a cell submitted to an apoptotic stimulus.
A high expression of Bcl-2 oncoprotein has often been correlated to a poor response to chemotherapy and/or a bad prognosis in both myeloid (Campos et al., 1993; Delia et al., 1992) and lymphoid malignancies (reviewed by Reed, 1995) . Overexpression of Bcl-2 in several cell models has allowed to establish its antiapoptotic eects against a variety of chemotherapeutic agents as inducers of apoptosis Reed, 1992, 1993) . However, the mechanism of action of Bcl-2-mediated protection is, at present, largely unknown. It appears therefore important to determine at which stage Bcl-2 interferes with the signalling pathway(s) of apoptosis.
A novel signaling pathway involving an early sphingomyelin (SM) cycle (hydrolysis and resynthesis) generating ceramide has been identi®ed in U937 and HL60 myeloid cells induced to undergo apoptosis with TNF-a (reviewed by Hannun, 1994) . This pathway appears to be used also by stress inducers of apoptosis (heat shock, u.v. or ionizing radiations, hydrogen peroxyde) (Haimovitz-Friedman et al., 1994; Verheij et al., 1996) . We recently demonstrated that daunorubicin (DNR), an anthracyclin widely used in the treatment of hematologic malignancies, triggers apoptosis in U937 and HL60 cells (Quillet-Mary et al., 1996) . Like TNF-a, DNR also induces activation of a neutral sphingomyelinase (SMase) that hydrolyses SM to produce ceramide . Other authors have identi®ed a ceramide synthase activity in U937 cells treated with high dose DNR at a later time during induction of apoptosis (Bose et al., 1995) . In this signaling pathway, ceramide seems to act as second messenger and addition of synthetic ceramide analogs or exposure to bacterial SMase mimicked the biological eects of TNF-a (Hannun, 1994) or DNR (Bose et al., 1995; .
In the present study we have used two cell models, one myeloid, the other lymphoid, both genetically engineered to overexpress Bcl-2, in order to: (1) establish whether Bcl-2 could protect leukemic cells against DNR-induced apoptosis; (2) better de®ne the level of intervention of Bcl-2 in the signaling cascade of apoptosis. Our results show that: (1) Bcl-2 delays apoptosis induced by DNR, both in a myeloid and a lymphoid cell lines, and (2) Bcl-2 acts downstream of the generation of ceramide.
Results

Expression of Bcl-2 and Bax proteins
We ®rst examined the relative levels of Bcl-2 in the control and Bcl-2 engineered cell lines. As shown in Western blot (Figure 1a ) and¯ow cytometry ( Figure  1b ), HL60/1C2 and BL/Bcl-2 expressed high levels of Bcl-2. The control cell line HL60/Neo was expressing Bcl-2, but with a mean¯uorescence intensity of one ®fth that of HL60/1C2 (Figure 1a and b, top left). Expression of Bcl-2 in the BL/SV2 cell line was very low, as the protein was only detected in¯ow cytometry ( Figure 1b , top right), but not in Western blotting (Figure 1a ). Since the function of Bcl-2 involves dimerization with homologous proteins such as Bax , we examined the level of Bax protein expression. Western blotting allowed to detect a band of the expected size (21 kDa) for the Bax protein in all four cell lines examined (not shown); however we also used¯ow cytometry, more sensitive for quanti®cation purposes. We found that the Bax protein is expressed at nearly identical levels in Bcl-2 transduced cell lines and in their respective counterparts (Figure 1b , bottom left and right).
Bcl-2 signi®cantly delays, but does not prevent cell death induced by DNR We examined the cell viability, using the trypan blue dye exclusion method, of all the cell lines treated by 1 mM DNR. As shown in Figure 2 , both HL60/Neo and BL/SV2 cells died within 48 h, whereas the number of total viable cells decreased slightly or remained stable for HL60/1C2 and BL/Bcl-2 cells, respectively, during the ®rst 48 h. Afterwhich, the cells died with similar kinetics as their control vector-transduced counterparts.
Cell death induced by DNR in Bcl-2-transduced and control cells is due to apoptosis In order to assess the nature of cell death induced by DNR, cells treated for various times with 1 mM DNR were examined with May ± GruÈ nwald ± Giemsa staining. Apoptotic ®gures were observed in HL60/Neo and BL/ SV2 cell lines as early as 6 h after drug exposure, and increased after 24 h (Figure 3a) . In contrast, the percentage of apoptotic cells remained below 10% at 24 h for the two Bcl-2 transduced cell lines (Figure 3a) . However, this percentage increased at later times of incubation (up to 39% and 33% apoptotic cells were detected for HL60/1C2 and BL/Bcl-2 at 72 h, respectively).
We have previously demonstrated that DNR induces DNA fragmentation in the HL60 myeloid cell line (Quillet-Mary et al., 1996) . As expected, control HL60/ Neo cells behaved as the parental cell line, with 82.6+9.3% DNA fragmentation after 6 h exposure to 1 mM DNR (Figure 3b, left) . In addition, we show here that DNR also induces DNA fragmentation in the Burkitt cell line BL/SV2, although with slower kinetics: 28.3+7.0% after 6 h drug exposure (Figure 3b, right) , increasing to 41.5+7.2% DNA fragmentation after 24 h. In contrast, overexpression of Bcl-2 prevented DNR-induced DNA fragmentation in the HL60/1C2 and BL/Bcl-2 cell lines treated for 6 (Figure 3b ) or 24 h.
Internucleosomal DNA fragmentation was clearly visualized, using conventional agarose gel electrophoresis, in HL60/Neo at 6 and 24 h after treatment, whereas it appeared later, starting at 24 h and increasing at 48 and 72 h, in HL60/1C2 cells ( Figure  3c ). In BL cells, however, we were unable to detect internucleosomal DNA fragmentation, although we observed smears starting at 24 h or at 48 h of incubation for the BL/SV2 and BL/Bcl-2 lines, respectively, and increasing thereafter (data not Taken together, these results indicate that cell death induced by DNR in the HL60 and BL cells is due to apoptosis, both in control and Bcl-2 overexpressing cells, the latter undergoing programmed cell death with a delay of 24 to 48 h.
DNR induces SM hydrolysis with concomitant ceramide generation both in Bcl-2-transduced and control cells
Our group has recently shown that, in cells sensitive to DNR-induced apoptosis, this drug stimulates an early cycle of SM hydrolysis with concomitant ceramide generation . In order to determine whether Bcl-2 could interfere with this signaling pathway (e.g., hypothesizing that Bcl-2-mediated protection could be due to a failure of ceramide generation), we quantitated total cell SM and ceramide at various times of incubation with 1 mM DNR. As expected, in control HL60/Neo cells, hydrolysis of SM appeared early and was concomitant to the generation of ceramide, occurring between 4 and 15 min of drug treatment (Figure 5a 
Exogenous ceramide induces DNA fragmentation in control, but not in Bcl-2-transduced cells
Since we did not detect a defect of ceramide generation in the Bcl-2-engineered cells, it was important to determine whether an exogenous ceramide could mimic the eects of DNR on these cells. Therefore we treated the cells, either with synthetic cell-permeant C2-or C6-ceramide, or with bacterial SMase (generating natural ceramide). As shown in Figure 6 , SMase as well as synthetic ceramide caused signi®cant DNA fragmentation in HL60/Neo cells within 6 h, but not in HL60/1C2. The eect of ceramide was speci®c since other lipid second messengers generated by treatment with other phospholipases such as phospholipase C (PLC) (Figure 6 ), PLD or PLA2 (data not shown) did not induce DNA fragmentation in the control HL60/Neo cells. Similar results were obtained with BL/SV2 and BL/Bcl-2 cells (data not shown). However, C6-ceramide induced a prolonged cell growth arrest in HL60/1C2 cells until 72 h (Figure 7) , after which cells started again to proliferate. Moreover, the cytostatic eect of C6-ceramide could be reproduced after readdition of the agent into the culture (data not shown). Thus Bcl-2 appeared to block exogenous ceramide-induced cytotoxicity.
Discussion
Our ®rst observation was that DNR induced apoptosis in both HL60 and BL cells. This had never been reported for DNR, to our knowledge, in the case of lymphoid cells. Apoptosis was identi®ed in both the myeloid and lymphoid cell lines by characteristic ®gures of cell shrinkage, DNA margination and condensation, and apoptotic bodies. Typical DNA ladders, revealing internucleosomal fragmentation, were clearly seen in HL60 cells. However, we could only detect smears in BL cells treated with DNR, in multiple experiments. The diculty to observe DNA laddering in lymphoid cell lines has been reported, and it appears not to be an absolute requirement in the de®nition of apoptosis (Catchpoole and Stewart, 1993; Falcieri et al., 1993; Fisher et al., 1993) . In addition, ®eld inversion gel electrophoresis allowed us to observe DNA macrofragments of 50 ± 150 kbp in both HL60 and BL cells, as previously described for epithelial cells (Oberhammer et al., 1993) , thymocytes (Brown et al., 1993; Walker et al., 1991) , and leukemic cells (Huang et al., 1995; QuilletMary et al., 1996) undergoing apoptosis induced by various agents. Therefore we conclude that both HL60 a b Figure 3 Characterization of apoptosis in Bcl-2-transduced and control HL60 and BL cell lines treated with 1 mM DNR. Detection of apoptosis was performed using three dierent methods: the percentage of apoptotic cells was evaluated by cell morphology analysis using May ± GruÈ nwald ± Giemsa staining (a), DNA fragmentation was quanti®ed by the [ The second observation was that Bcl-2`inhibited' DNR-induced apoptosis in HL60 and BL cells. It was somewhat predictable, as Bcl-2 has been shown to protect a variety of hematopoietic and non hematopoietic cell types against an array of chemotherapeutic agents (reviewed by Hickman, 1992; Reed, 1995) . However, it should be stressed that this inhibition was only transitory, and that Bcl-2 expressing cells eventually died of apoptosis. This delayed cell death eect has also been observed after overexpression of Bcl-2 (Yin and Schimke, 1995), or of other Bcl-2 family members such as Mcl-1 (Reynolds et al., 1994) and A1 in other cell types. Therefore, the overexpression of Bcl-2 seems to confer a survival advantage to the cells rather than a de®nitive protection. However, it is likely that this advantage can result in the expansion of a tumor by modifying the balance between the pools of living/dividing and of dying cells.
The function of Bcl-2 has been linked to its ability to form heterodimers with the homologue protein Bax . Therefore we have examined the expression of Bax in all cell lines under study. We did not detect any signi®cant dierence in Bax protein expression between the control (HL60/Neo and BL/ SV2) cell lines and their Bcl-2-transduced counterparts (HL60/1C2 and BL/Bcl-2), respectively. It may seem surprising though, that BL/SV2 cells, which have nearly no Bcl-2, are less sensitive to DNR-induced apoptosis than HL60/Neo, which constitutively express Bcl-2 at a non negligible level, whereas both cell lines express similar levels of Bax protein. We can exclude EBV-speci®c mechanisms of cell protection, mediated by EBV genes such as BHRF1, a Bcl-2 functional and structural homologue (Henderson et al., 1993) and LMP-1, a late membrane protein, reported to upregulate Bcl-2 (Henderson et al., 1991) , since the BL cell line under study displays the latency I form of infection, in which only the nuclear antigen EBNA 1 is expressed. Our results suggest that knowing the basal levels of one or even two proteins of the Bcl-2 family does not provide sucient information to predict the cell's response to a damaging agent.
The mechanism of action of the Bcl-2 gene product has remained elusive up to now. It has been suggested that Bcl-2 has antioxidant properties and inhibits apoptosis by suppressing the formation or eects of reactive oxygen species (Hockenberry et al., 1993) . This is an attractive hypothesis considering the fact that the anthracyclin DNR forms semi-quinone free radicals and oxy-radicals (Sinha and Minnaugh, 1990), thus most likely inducing an oxidative stress. Moreover, we have previously reported that antioxidants such as N-acetylcysteine and pirrolidine dithiocarbamate (PDTC) block DNR-induced apoptosis (QuilletMary et al., 1996) . However, this antioxidant mechanism cannot always be invoked, as Bcl-2 can also protect cells against apoptosis in near-anaerobic conditions, as well as against hypoxia-induced programmed cell death (Jacobson and Ra, 1995; Shimizu et al., 1995) .
Alternatively, one can speculate that Bcl-2 may interfere with the signaling pathway which initiates DNR-triggered apoptosis. As recently reported by our group, this cascade of events includes an early SM hydrolysis cycle leading to ceramide generation (JareÂ zou et al., 1996), similarly to observations made earlier for programmed cell death induced by TNF-a 
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Bcl-2 and the ceramide pathway of apoptosis M Allouche et al (Hannun, 1994) . Other authors have identi®ed a ceramide synthase activity at a later time during induction of apoptosis by DNR (Bose et al., 1995) . Since ceramide appears to play a key role in the signaling pathway which leads to apoptosis in leukemic cells treated with DNR (Bose et al., 1995; , it was important to determine whether thè protection' of the cells overexpressing Bcl-2 was due to a lack of ceramide generation, or to a blockade downstream of this event. In this report we demonstrate: (1) a hydrolysis of SM concomitant to a ceramide generation in HL60/Neo control cells treated with DNR; (2) a similar generation of ceramide induced by DNR in the BL/SV2 B lymphoid cell line, a ®nding never reported before in Burkitt lymphoma derived cells; (3) and, most importantly, an unmodi®ed generation of ceramide in both the myeloid and the lymphoid Bcl-2 engineered cell lines HL60/1C2 and BL/Bcl-2, respectively. Therefore, our results clearly demonstrate that Bcl-2 does not impair the generation of ceramide induced by an agonist of the SM-ceramide pathway, which induces apoptosis in leukemic cells. Therefore, we investigated the possible role of Bcl-2 in ceramide-induced apoptosis in HL60 and BL cells. As expected from previous studies (Fang et al., 1995; Martin et al., 1995) , Bcl-2 overexpression blocked DNA fragmentation induced by permeant ceramide. Moreover, we found that, in Bcl-2-transduced cells, permeant ceramide induced a Bcl-2 and the ceramide pathway of apoptosis M Allouche et al transient cytostatic eect followed by cell growth recovery after 72 h. The ®nding that Bcl-2 only delayed DNR-induced, whereas it totally blocked exogenous ceramide-induced apoptosis could have several explanations: (1) the intra-cellular molarity, repartition and fate of permeant ceramide are probably dierent from those of endogenously generated ceramide, e.g., after DNR treatment; (2) DNR may operate via multiple death signaling pathways, one of those being featured by ceramide signaling; (3) the most likely hypothesis is that DNR operates via the ceramide pathway in control, but not in Bcl-2 overexpressing cells. Thus, one could hypothesize that DNR can activate apoptosis through ceramide-dependent or -independent mechanisms, according to Bcl-2 expression levels.
The molecular basis of ceramide-induced apoptosis is poorly understood. Multiple targets for the direct or indirect action of ceramide have been identi®ed (for review, see Pushkareva et al., 1995; Levade et al., 1996) . More recently, the activation of the stressactivated protein kinase (SAPK/JNK) (Verheij et al., 1996; Westwick et al., 1995) , has been described as part of this signal transduction pathway. According to a recently published study by Cuvillier et al. (1996) , the fate of the cells might be determined by the balance between the intra-cellular levels of ceramide and its down-product, sphingosine-1-phosphate (SPP), and their respective eects on the extra-cellular signalregulated kinase (ERK) and SAPK/JNK pathways (Xia et al., 1995) . It is also worthy to note that a member of the ICE family of cysteine proteases, prICE/CPP32/apopain was recently identi®ed as a downstream target for ceramide-induced apoptosis and that the cleavage of poly(ADP-ribose) polymerase (PARP) by this enzyme was inhibited by overexpression of Bcl-2 (Smyth et al., 1996) .
While this manuscript was being completed, another group came to similar conclusions as ours, with dierent cell models (pre-B and T lymphoid cell lines), apoptosis inducer (vincristine, another antileukemic agent) and time of ceramide generation (8 h after drug exposure), that Bcl-2 does not block ceramide generation . In concert, our studies demonstrate that Bcl-2 does not prevent the generation of ceramide, suggesting that Bcl-2 operates downstream of the ceramide pathway of cell death.
Materials and methods
Reagents DNR (Cerubidine 1 ) was purchased from Laboratoire Roger Bellon (Neuilly-sur-Seine, France). [Methyl- 3 H]-thymidine (79 Ci/mmol), and [9,10(n)-3 H]-palmitic acid (53 Ci/mmol) were purchased from Amersham (Les Ulis, France). [Methyl- 3 H]-choline chloride (81 Ci/mmol) was from Du Pont-NEN (Les Ulis, France). All other drugs and reagents were purchased from Sigma Chemical Co (St Louis, MO, USA).
Cells
All the cell lines were cultured in RPMI 1640 supplemented with 10% fetal calf serum (FCS), 2 mM L-glutamine, 100 mg/mL streptomycin and 200 U/mL penicillin (complete medium; GIBCO, Grand Island, NY). HL60/Neo and HL60/Bcl-2 were derived from the myeloid cell line HL60, infected with the control neomycin or Bcl-2 retroviruses, respectively, as previously described (Naumovski and Cleary, 1994) . HL60/1C2 was subcloned by limiting dilution from the HL60/Bcl-2 cell line. BL/SV2 and BL/ Bcl-2 cell lines (Milner et al., 1992) were derived from a patient's Burkitt lymphoma (MUTU-BL group I, clone 61E), bearing the t(4;18) translocation and transfected with the pCDj-SV2 and pCDj-Bcl-2 plasmids (Tsujimoto, 1989) containing the Neo, or Neo and bcl-2 cDNAs, respectively. Cells were reselected every month with G418 for two consecutive passages.
Western blot
Aliquots of 5610 6 cells were washed once with phosphatebuered saline (PBS), pelleted and extracted in lysis buer 
of three independent experiments
Bcl-2 and the ceramide pathway of apoptosis M Allouche et al (50 mM Tris HCl, pH 8.0, 150 mM NaCl, 1% NP40, 10 mg/ mL leupeptin, 2 mg/mL aprotinin, 2 mg/mL pepstatin A, 2 mg/mL chymostatin and 0.5 mM phenylmethylsulfonyluoride (PMSF) for 45 min on ice. Cell extracts were then centrifuged at 10 000 g for 20 min at 48C. The supernatant was recovered and its protein content was quantitated by the Bio-Rad (Ivry/Seine, France) protein assay. For Western blot, 15 ± 30 mg total cell proteins were subjected to SDS ± PAGE (Laemmli, 1970) in a 10% gel under reducing conditions, and transferred for 2 h at 60 V, 48C onto a nitrocellulose membrane (Towbin et al., 1979) . Antibodies used for immunodetection were: a mouse monoclonal anti-human Bcl-2 antibody at 1/200 (Dako, Glostrup, Denmark), followed by a horseradish peroxidase-coupled rabbit anti-mouse Ig antiserum (Dako; 1/ 1000). Detection was performed with an enhanced chemoluminescence kit (ECL: Amersham).
Flow cytometry
Exponentially growing cells were washed in PBS, ®xed in 0.25% formaldehyde for 30 min at 48C, washed twice in PBS, and permeabilized with 1% saponin for 30 min at room temperature. After two washes in PBS containing 1% bovine serum albumine and 0.1% sodium azide, cells were incubated with 5 mL of pure primary antibody for 30 min at 48C, i.e.: mouse monoclonal anti-human Bcl-2 antibody (Dako) or polyclonal rabbit anti-human Bax antibody (Santa Cruz Biotechnology, Santa Cruz, Ca). After two washes, cells were incubated for 30 min at 48C with secondary reagents:¯uorescein isothiocyanate (FITC)-coupled goat anti-mouse Ig (Jackson Immunoresearch, West Grove, Pa; 1/50) or FITC-coupled goat anti-rabbit Ig (Zymed, Burlingame, Ca; 1/500) antisera, respectively. After labeling, cells were washed twice and ®xed again in 0.5% formaldehyde. Fluorescence was analysed on a FACScan¯ow cytometer (Becton-Dickinson, San Jose, Ca).
Cell viability
Exponentially growing cells were exposed to 1 mM of DNR for various times up to 96 h. The modality of treatment had been selected for optimal induction of apoptosis in each cell line. HL60/Neo and HL60/1C2 cells were treated for 1 h, washed twice and further incubated in drug-free medium, whereas drug exposure was continuous for BL/ SV2 and BL/Bcl-2 cells. Cell viability was measured by the trypan blue dye exclusion method.
Cell morphology
Treated and untreated cells were washed twice with PBS. Aliquots of cell suspensions were ®xed onto microscope slides by cytospin, stained with May ± GruÈ nwald ± Giemsa dye and examined under the light microscope. Extent of apoptosis was determined by the number of cells undergoing a reduction of cell volume with chromatin condensation or micronuclear fragmentation.
Quanti®cation of DNA fragmentation
Exponentially growing cells (2610 5 cells/mL) were labeled with 0.5 mCi/10 6 cells of [methyl-3 H]-thymidine for 24 h and washed three times with non radioactive fresh medium. Labeled cells were exposed to 1 mM of DNR for 6 h continuous exposure. Cells were harvested by centrifugation and the pellets were resuspended in lysis buer containing Tris 15 mM, ethylenediaminetetraacetate (EDTA) 20 mM, Triton X-100 0.5%, pH 8.0. After incubating on ice for 30 min, samples were centrifuged at 20 000 g for 30 min at 48C. Pellets were resuspended in lysis buer. The supernatant (detergent soluble low molecular weight DNA) and pellet (intact chromatin DNA or large chromatin fragments) radioactivity was determined by liquid scintillation counting. Results were expressed as the percentage of fragmented DNA, in which the spontaneous DNA fragmentation of untreated cells had been subtracted, as previously described (Quillet-Mary et al., 1996) .
DNA isolation and gel electrophoresis
Cells treated for various times with DNR were washed in PBS, and the cell pellet was resuspended in a solution containing 150 mM NaCl, 15 mM sodium citrate, pH 7.0, 10 mM EDTA, 1% (w/v) sodium lauryl sarcosinate and 0.5 mg/mL proteinase K. Proteolytic digestion was allowed to proceed for 6 h at 508C. The DNA was precipitated overnight at 7208C with two volumes absolute ethanol, resuspended in 10 mM Tris-HCl, 1 mM EDTA buer, pH 8.0 and treated with 1 mg/mL RNase for 30 min at 378C prior to loading onto a 1.8% agarose gel. DNA was visualized by ethidium bromide staining under ultraviolet light.
Field inversion gel electrophoresis
Field inversion gel electrophoresis was conducted according to a previously published method (Gromova et al., 1995) . After DNR treatment, 5610 6 cells were embedded in 0.7% low-melting agarose (Sea Plaque Agarose, FMC Bioproducts, USA). Agarose plugs were incubated 36 h at 508C in 0.2 M EDTA, pH 8.0 containing 1 mg/mL proteinase K, with gentle rotation. Plugs were then washed three times for 1 h in 0.2 M EDTA at 48C and stored in this solution at 48C prior to analysis. Samples, including a 50 ± 1000 kilobasepairs lambda DNA standard (Promega Corporation, Madison, USA) were analysed on a 1% agarose gel using a SwitchBack TM Pulse Controller pulse-®eld electrophoresis system (Hoefer Scienti®c Instruments, San Francisco, Ca) at 100 V with pulse ramping times from 1 to 20 s (forward/backward ratio 3 : 1) for 18 h in a 0.56TBE buer (45 mM Tris-borate, 1 mM EDTA, pH 8.6). The buer was recirculated continuously at room temperature. The gel was photographed after staining with ethidium bromide (0.5 mg/mL).
Metabolic cell labelling and sphingolipid quantitation
For SM quantitation, cells were incubated at 3.5610 5 /mL for 48 h in RPMI 1640 containing 1% FCS and 0.4 mCi/ mL of [methyl- 3 H]-choline (speci®c activity 81.0 Ci/mmol, DuPont-NEN, Les Ulis, France). Cells were then washed and resuspended in serum-free medium with or without DNR for various times. At the end of these times, cells were collected and stimulation was stopped by immersion of the samples in liquid nitrogen. For extraction and separation of labeled SM, frozen cell aliquots were thawed, and sonicated for 3615 s (Soniprep MSE sonicator). An aliquot was taken for protein determination and the remaining was extracted with 2.5 mL of chloroform : methanol (2 : 1, vol/vol), vortex mixed, and centrifuged at 1000 g for 15 min (Folch et al., 1957) . Radioactive SM was isolated as previously described and quantitated by liquid scintillation counting.
For total cellular ceramide quantitation, cells were incubated in RPMI 1640 containing 1% FCS and [9,10(n)-3 H]-palmitic acid (1 mCi/mL). After 48 h incubation, the radioactive medium was removed and cells were incubated for 2 ± 4 h in 1% FCS enriched medium. Cells (5610 6 resuspended in 3 mL of RPMI 1640 medium supplemented with 25 mM HEPES) were treated with 1 mM DNR for various times and harvested. Lipids were extracted 
